quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 6, 2026

Amazon Q4 Earnings Miss Estimates, Shares Slide on $200B Capex Plan

View original at finance.yahoo.com
Amazon Q4 Earnings Miss Estimates, Shares Slide on $200B Capex Plan Amazon.com AMZN shares dipped in after-hours trading on Thursday after the company delivered fourth-quarter 2025 earnings of $1.95 per share, which increased 5% from the year-ago quarter but fell short of the consensus estimate by 1.52%…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Shoppers using Rufus show 60% higher purchase completion rates

    80% confidence
  • Plans to invest approximately $200 billion in capital expenditures in 2026, predominantly in AWS

    80% confidence
  • Net sales guidance for Q1 2026 is between $173.5 billion and $178.5 billion, representing 11% to 15% growth

    80% confidence
  • Graviton is used by more than 90% of the top 1,000 AWS customers

    80% confidence
  • Operating income guidance for Q1 2026 is expected to range between $16.5 billion and $21.5 billion

    80% confidence
  • Plans more than 20 Amazon LEO satellite launches in 2026 and over 30 in 2027

    80% confidence
  • AWS custom chips business including Trainium and Graviton now has a combined annual revenue run rate of more than $10 billion and is growing at triple-digit percentages year over year

    80% confidence
  • Amazon Bedrock is now a multibillion-dollar annualized run rate business with customer spend growing 60% quarter over quarter

    80% confidence
  • Trainium4 is expected to start delivering in 2027

    80% confidence
  • Graviton5 is up to 40% more price-performant than leading x86 processors

    80% confidence
  • Amazon LEO commercial rollout is expected later in 2026

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Amazon Q4 Earnings Miss Estimates, Shares Slide on $200B Capex Plan — Source | Via News | pt.VIA.NEWS